Reports for TEVA CANADA LIMITED

Company Name
TEVA CANADA LIMITED

Shortage reports

Actual shortage:

283 (9%)

Anticipated shortage:

1 (0%)

Avoided shortage:

10 (0%)

Resolved:

2953 (91%)

3247

Discontinuation Reports

To be discontinued:

2 (0%)

Discontinued:

410 (94%)

Reversed:

23 (5%)

435

483 (13%)

16 (6%)

Shortage reports
Brand name Strength Dosage Status Date Created Date Updated Reports
TEVA-BUPROPION XL 150MG TABLET (EXTENDED-RELEASE) Resolved 2022-03-10 2022-03-24 156407
TEVA-BUPROPION XL 150MG TABLET (EXTENDED-RELEASE) Resolved 2022-05-12 2022-11-12 160427
TEVA-BUPROPION XL 300MG TABLET (EXTENDED-RELEASE) Actual shortage 2026-01-08 2026-01-09 275543
TEVA-BUPROPION XL 300MG TABLET (EXTENDED-RELEASE) Resolved 2024-04-05 2024-06-07 224445
TEVA-BUPROPION XL 300MG TABLET (EXTENDED-RELEASE) Resolved 2021-06-10 2021-09-30 140675
TEVA-BUPROPION XL 150MG TABLET (EXTENDED-RELEASE) Resolved 2024-06-20 2025-02-06 230961
TEVA-BUPROPION XL 150MG TABLET (EXTENDED-RELEASE) Resolved 2020-07-09 2020-08-27 119889
TEVA-BUPROPION XL 300MG TABLET (EXTENDED-RELEASE) Resolved 2022-05-12 2022-11-12 160432
TEVA-BUPROPION XL 300MG TABLET (EXTENDED-RELEASE) Resolved 2024-06-20 2025-01-30 230958
TEVA-BUPROPION XL 150MG TABLET (EXTENDED-RELEASE) Resolved 2024-01-11 2024-02-22 215743
TEVA-BUPROPION XL 150MG TABLET (EXTENDED-RELEASE) Resolved 2021-02-11 2021-04-29 133770
TEVA-BUPROPION XL 300MG TABLET (EXTENDED-RELEASE) Resolved 2023-11-09 2023-12-07 209672
TEVA-BUPROPION XL 150MG TABLET (EXTENDED-RELEASE) Resolved 2024-07-11 2025-02-20 232747
TEVA-BUPROPION XL 300MG TABLET (EXTENDED-RELEASE) Resolved 2022-02-17 2022-03-24 155137
TEVA-BUPROPION XL 300MG TABLET (EXTENDED-RELEASE) Resolved 2020-07-16 2021-09-30 120473
TEVA-BUPROPION XL 150MG TABLET (EXTENDED-RELEASE) Resolved 2022-01-27 2022-11-12 153709
TEVA-BUPROPION XL 300MG TABLET (EXTENDED-RELEASE) Resolved 2023-04-27 2023-06-09 190728
TEVA-BUPROPION XL 150MG TABLET (EXTENDED-RELEASE) Resolved 2021-02-11 2021-05-27 133776
TEVA-BUPROPION XL 150MG TABLET (EXTENDED-RELEASE) Resolved 2025-02-20 2025-03-27 250909
TEVA-BUPROPION XL 300MG TABLET (EXTENDED-RELEASE) Resolved 2025-01-23 2025-03-04 248445
Discontinuation reports
Brand name Strength Dosage Status Date Created Date Updated Reports
HYDROCORTISONE SODIUM SUCCINATE FOR INJECTION Discontinued 2019-04-11 2019-04-11 81344
HYDROCORTISONE SODIUM SUCCINATE INJECTION Discontinued 2019-04-11 2019-04-11 81347
IRINOTECAN FOR INJECTION 20MG SOLUTION Discontinued 2025-05-28 2025-05-28 258762
LEUCOVORIN CALCIUM INJECTION 10MG SOLUTION Discontinued 2017-06-27 2017-06-27 14036
LINEZOLID INJECTION Discontinued 2020-02-13 2020-02-13 106173
METHOTREXATE SODIUM INJECTION 25MG SOLUTION Discontinued 2025-05-28 2025-05-28 258481
METHOTREXATE SODIUM INJECTION 25MG SOLUTION Discontinued 2025-04-25 2025-04-25 255818
METHYLPREDNISOLONE SODIUM SUCCINATE FOR INJECTION 40MG POWDER FOR SOLUTION Discontinued 2021-09-23 2021-09-23 146061
NOVAMOXIN 250MG GRANULES FOR SUSPENSION Discontinued 2019-04-11 2019-04-11 81316
NOVAMOXIN 125MG TABLET (CHEWABLE) Discontinued 2019-10-25 2019-10-26 97251
NOVAMOXIN 25MG GRANULES FOR SUSPENSION Discontinued 2019-04-11 2019-04-11 81393
NOVAMOXIN 125MG TABLET (CHEWABLE) Discontinued 2019-04-11 2019-04-11 81321
NOVAMOXIN 500MG CAPSULE Discontinued 2017-06-27 2017-06-27 14046
NOVAMOXIN 250MG CAPSULE Discontinued 2020-01-24 2020-01-24 104289
NOVASEN 650MG TABLET (DELAYED-RELEASE) Discontinued 2018-10-12 2018-10-12 63964
NOVASEN 325MG TABLET (DELAYED-RELEASE) Discontinued 2018-10-12 2018-10-12 63959
NOVASEN 325MG TABLET (DELAYED-RELEASE) Discontinued 2018-10-12 2018-10-12 63955
NOVO-PROFEN 400MG TABLET Discontinued 2018-10-19 2018-10-19 64920
NOVO-PROFEN 200MG TABLET Discontinued 2019-04-11 2019-04-11 81310
PIPERACILLIN / TAZOBACTAM POWDER FOR INJECTION 4G 0.5G POWDER FOR SOLUTION Discontinued 2025-05-28 2025-05-28 258717

Showing 101 to 120 of 435